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Abstract 
Several reports suggest garlic supplements may inhibit the metabolism of 
cytochrome P450 (CYP) 2C9 and CYP3A4 substrates, such as warfarin and 
saquinavir. To characterize the effects of garlic extract on CYP2C9 and 
CYP3A4 enzyme activity immortalized human hepatocytes (Fa2N-4 cells) were 
exposed to garlic extract (0–200  μg/mL). CYP2C9 and CYP3A4 enzyme 
activities were evaluated in parallel with enzymatic activities, expression of 
respective RNA transcripts was also assessed. 
Exposure to increasing concentrations of garlic extract led to progressive 
reduction in Fa2N-4 CYP2C9 activity as detected by diclofenac hydroxylation. 
CYP2C9 mRNA expression also revealed a concentration-dependent 
reduction. Greater than 90% reduction in CYP2C9 activity was observed 
following four days of exposure to 50 μg/mL garlic extract. In contrast, exposure 
to garlic extract had no effect on the CYP3A4 enzymatic activity or RNA 
transcript concentration in Fa2N-4. Therefore, suppression of CYP2C9 
expression and activity is a heretofore unrecognized mechanism by which 
garlic extract may modulate CYP activity. Exposure of hepatocytes to garlic 
extract may reduce the expression and activity of CYP2C9 with no detectible 
effects on CYP3A4. 474  B. E. Ho et al.  
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Introduction 
Garlic supplements are amongst the top ten best selling herbal supplements, which leads 
to concern over the reported garlic-drug interactions [1–3]. The well-known adverse 
interaction between garlic and warfarin, a cytochrome P450 (CYP) 2C9 enzyme substrate, 
is presumably due to the antiplatelet effects of garlic [4]. The administration of enteric 
coated 2g/dose x twice daily garlic for two weeks did not alter warfarin pharmacokinetics or 
its effects in healthy male volunteers [5]. Chronic (i.e., greater than 21-days) ingestion of 
garlic powder leads to increased clearance of saquinavir, a CYP3A4 and p-glycoprotein 
substrate [6, 7]. These data suggest that garlic may induce both CYP2C9 and CYP3A4 
activities, possibly due to activation of shared regulatory mechanisms [e.g. constitutive 
androstane receptor (CAR)] for their gene transcription. 
Two in vitro studies on cell-free enzymes [8,  9] demonstrated that garlic constituents 
competitively inhibit several recombinant CYP enzymes, namely CYP2C9, CYP2C19 and 
CYP3A4. Aqueous extracts from odorless garlic products inhibited CYP3A4 (range of 
inhibition by the six separate products, 30.8–53.8%) to a slightly greater extent than 
CYP2C9 (range of inhibition: 4.8–33.5%). Steam-distilled garlic oil inhibited CYP2C9 and 
CYP3A4 to a comparable extent on average, while freeze-dried garlic tablets did not inhibit 
CYP2C9 activity [8]. Allicin, a major organosulfur constituent of some garlic supplements, 
was a more potent inhibitor of cDNA-expressed CYP2C9 than CYP3A4 (IC50 5.4 vs. 
43.7 µM, respectively) [8]. On the other hand, a human microsomal P450 activity study 
suggested that only two garlic constituents, S-allyl- or S-methyl-L-cysteine at 0.1 mg/mL 
significantly inhibited CYP3A4 with no impact on CYP2C9, CYP2C19 or CYP1A2 [10]. 
The limitation of cell free microsomes or recombinant enzymes in studying the effect of 
garlic extract on CYP regulation can be overcome by turning to primary human 
hepatocytes. Unfortunately, inconsistent availability and the high cost of primary human 
hepatocytes are major hurdles. Recently, an immortalized human hepatocyte, Fa2N-4 cell 
line was shown to exhibit characteristics similar to that of primary hepatocytes, particularly 
induction and inhibition of CYP enzymes. The Fa2N-4 cells are responsive to rifampin’s 
induction of CYP2C9 and CYP3A4 at a magnitude similar to that of primary human 
hepatocytes [11]. Therefore, we used the Fa2N-4 cells to evaluate the effects of garlic 
extract on the expression and activity of CYP2C9 and CYP3A4 in the cells. 
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Results and Discussion 
Rifampin successfully induced CYP2C9 and CYP3A4 activity and mRNA expression in the 
Fa2N-4 cells, which confirms the responsiveness of this immortalized cell line to CYP 
induction (Tables 1 and 2). As shown in Table 1, CYP2C9 activity in Fa2N-4 cells was 
induced by rifampin to 0.95-2.48 fold compared to media control exposure. Under the 
same conditions, exposure of Fa2N-4 cells to either 100 or 200 μg/mL garlic significantly 
reduced CYP2C9 activity in a concentration- and time-dependent manner. By days three 
and four, both 100 and 200 μg/mL concentrations of garlic lowered CYP2C9 activity to 
nearly undetectable levels (Table 1). We next replicated the experiment to determine 
whether at lower garlic concentrations, CYP2C9 activity could be induced (Table 2). We 
found that at 50 μg/mL, garlic could still suppress hydroxylation of diclofenac by >90% at 
day four. With respect to CYP3A4 activity, exposure of Fa2N-4 to varying concentrations 
of garlic extract did not alter CYP3A4 activity (Table 2). 
Tab. 1.   Effects of Garlic on CYP2C9 activity 
Diclofenac hydroxylation on day
a  Treatment 
1 2 3 4 
Control  1.00 ± 0.07
b 1.00 ± 0.01  1.00 ± 0.05  1.00 ± 0.04 
Rifampin 10 μM  0.95 ± 0.06  1.13 ± 0.04  2.48 ± 0.04  2.14 ± 0.08 
Garlic 100 μg/mL  0.54 ± 0.03  0.35 ± 0.08  0.18 ± 0.06  0.04 ± 0.05 
Garlic 200 μg/mL  0.26 ± 0.11  0.04 ± 0.28  ND*  ND 
a Fa2N-4 cells were exposed to rifampin or garlic at 100 or 200 μg/mL and on indicated 
days, were exposed to diclofenac for six hours. The CYP2C9 activity was assessed by 
detecting hydroxylation of diclofenac, and is expressed as fold increase over that of 
media-treated control; 
b Data expressed were the ratio of garlic or rifampin-treated 
versus control as mean ± one standard deviation of quadruplicate replicates; * ND = 
Non detectable level 
 
We also determined the effects of garlic on RNA transcripts of CYP2C9 and CYP3A4 in 
Fa2N-4 cells. The RNA levels were determined on day four using a validated, quantitative 
RT-PCR assay for each of the target gene transcripts. As shown in Table 2, exposure of 
these cells to rifampin induces both CYP2C9 and CYP3A4 mRNA transcripts by about 
four-fold compared to control medium. When the same cells were exposed to garlic, 
CYP2C9 showed a garlic concentration-dependent reduction in transcript levels. In 
contrast, exposure to even up to 100 μg/mL of garlic extract did not appear to significantly 
alter the CYP3A4 transcript concentration in hepatocytes. These results suggest that garlic 
extract had a selective suppressive effect on the mRNA expression of CYP2C9 in Fa2N-4 
hepatocytes. Taken together, the enzymatic activity of CYP2C9 and CYP3A4 in these 
hepatocytes appeared to have tracked the effects of garlic on RNA transcript levels. 
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Tab. 2.   Effects of Garlic on CYP2C9 and CYP3A4 activity and mRNA expression by 
day four of treatment
a 
CYP2C9 CYP3A4 
Treatment
b  Activity
b 
(diclofenac 
hydroxylation)
a
mRNA 
transcripts
c 
Activity
b 
(midazolam 
hydroxylation) 
mRNA 
transcripts
c 
Control  1.00 ± 0.10  1.03 ± 0.24  1.00 ± 0.04  0.07 ± 0.14 
Rifampin 10 μM  5.74 ± 0.63  4.14 ± 0.54  7.75 ± 0.30  4.11 ± 0.24 
Garlic 5 µg/mL  0.93 ± 0.20
  1.01 ± 0.40  1.06 ± 0.21  1.11 ± 0.41 
Garlic 25 μg/mL
  1.25 ± 0.08
  0.93 ± 0.02  1.13 ± 0.10  0.73 ± 0.25 
Garlic 50 μg/ mL
  0.09 ± 0.01
  0.33 ± 0.20  1.16 ± 0.10  0.70 ± 0.34 
Garlic 100 μg/mL
  0.17 ± 0.21
  0.04 ± 0.02  1.03 ± 0.10  1.12 ± 0.33 
a Data expressed were the ratio of garlic or rifampin-treated versus control as mean ± one standard 
deviation of four replicates; 
b Fa2N-4 cells were exposed to rifampin and varying concentrations of 
garlic for four days. On day four, the cells were exposed to diclofenac for six hours and midazolam for 
15 minutes. The fold induction was compared to that of a media-treated control; 
c On day four of 
treatment, cells were removed and real time RT-PCR assay was used to determine the levels of RNA 
transcript from CYP 2C9 and CYP3A4. The transcript level reflects the enzymatic activity of the 
hepatocytes; * ND = Not determined. 
 
Although it has been suggested that garlic supplements may induce CYP activity in vivo, 
there is little direct evidence that garlic extract up-regulates human CYP2C9 or CYP3A4 
expression. Using a novel immortalized hepatocyte Fa2N-4 cell line that exhibits similar 
characteristics as those of primary human hepatocytes, we have systematically studied the 
modulating effects of garlic extract on CYP 2C9 and CYP3A4 mRNA expression and 
catalytic activity. Our results show that garlic suppresses CYP2C9 expression and activity 
in a remarkable, concentration-dependent manner, but that garlic has no discernable effect 
on CYP3A4 within the same cells. The changes in CYP2C9 activity paralleled those of 
RNA transcript levels. The decrease in transcript concentration is not due to any 
detrimental effects of garlic extract on cell viability, since expression and activity of 
CYP3A4 were maintained in the same cells. Also, the degree of induction observed with 
rifampin in our Fa2N-4 cultures (Table 2) is comparable to that reported by others [11]. In 
regards to mechanism, the decrease in CYP2C9 transcript could reflect either reduction in 
transcription or increased RNA degradation, or both. As CYP3A4 transcription is not 
affected by garlic exposure, it appears that the putative effects of garlic on intracellular 
transcription or message destabilization are a target-gene specific process. The exact 
mechanism awaits further investigation. It should be noted that garlic extract could also 
directly inhibit CYP2C9, but not CYP3A4 activity. Using cDNA expressed recombinant 
CYP3A4 enzyme, in microsome (cell-free) preparations, Foster et al. have shown that 
various preparations of garlic extract at a fixed 25 mg/mL concentration inhibited CYP3A4 
and CYP2C9 activity [9]. It is not known whether garlic extract at the much lower 
concentrations employed in our experiments (between 5-200 μg/mL) can directly inhibit 
CYP2C9 activity (Tables 1 and 2). Nonetheless, it is clear that the activity of CYP3A4 in 
Fa2N-4 was not affected by the chosen medium concentrations of garlic extract (Table 2). 
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It has been proposed that garlic supplements’ effects on CYP3A4 in humans is likely to be 
biphasic in nature; that is, inhibition during the early phase of treatment [8,  9], and 
simultaneous inhibition and induction following chronic treatment. This hypothesis is 
supported by the minimal effects of short term exposure (four to five days) to garlic on 
modifying the area under the concentration-time curve (AUC) of a single dose of ritonavir, 
a substrate for CYP3A4 [12]. Chronic (i.e., 21-days) administration of dehydrated garlic 
(Natrol's GarliPure™ caplets BID) significantly reduced the AUC and Cmax of the HIV 
protease inhibitor saquinavir (a CYP3A4 and P glycoprotein substrate) in nine healthy 
volunteers [6]. It was proposed that garlic constituents lowered the saquinavir plasma 
concentrations by inducing the drug-metabolizing enzyme CYP3A4 in the intestine and the 
liver, and/or the membrane efflux transporter P-glycoprotein at the intestinal mucosa. 
CYP3A4 activity was not affected by 14-day administration of a different dehydrated garlic 
product (Kwai garlic supplement, three tablets BID) [13]. Only one study to date has 
examined the effects of steam-distilled garlic oil on CYP3A4; midazolam hydroxylation, a 
marker of CYP3A4, was not affected by steam-distilled garlic oil (500 mg TID for 28 days) 
[14]. It appears that garlic has an equivocal effect on hepatic CYP3A4 that may be 
substrate-dependent. 
Given the remarkable ability for garlic extract to suppress the expression and activity of 
CYP2C9 in Fa2N-4 cells and previous reports of its direct competitive inhibition of 
CYP2C9, garlic supplements may interact with drugs that are CYP2C9 substrates with 
narrow therapeutic indices or notable adverse reactions. For example, celecoxib is 
extensively metabolized by CYP2C9 [15–17] for which dose-dependent cardiotoxicity has 
been a concern. In addition to celecoxib, garlic supplements may interact with other drugs 
metabolized by CYP2C9, such as the antiplatelet drug cilostazol, and the antidiabetic 
agent glyburide [18]. 
Conclusions 
We have shown that garlic extract suppresses CYP2C9 activity without affecting CYP3A4 
in Fa2N-4 hepatocytes. As the Fa2N-4 cell line is an acceptable model of human primary 
hepatocytes, these data suggest that the concomitant administration of garlic supplements 
with CYP2C9 substrates may lower metabolic clearance of the CYP2C9 substrates and 
potentially precipitate adverse drug reactions. 
Experimental 
Rifampin – 3-{[(4-methylpiperazin-1-yl)imino]methyl}rifamycin SV – and diclofenac were 
purchased from Sigma-Aldrich (St. Louis, MO). 4'-Hydroxydiclofenac was purchased from 
BD Gentest (Woburn, MA). Midazolam (M-908) and α-hydroxymidazolam (H-902) were 
purchased from Cerillant (Round Rock, TX). Garlic extract was prepared from a 350 mg 
Garlicin™ tablet (dehydrated garlic preparation from Nature’s Way, Springville, Utah). The 
final preparation contained 3,200 μg allicin in 10 mL of phosphate buffered saline at pH 7.4 
and was independently verified to be within 5% of the indicated allicin concentration. Three 
batches of this extract were used to replicate the results. A single batch of stock solution 
was prepared, aliquots of which were frozen at -80
◦C pending use. Frozen aliquots were 
defrosted immediately prior to experiments and discarded after each use. All other 
reagents were analytical grade or higher. Human liver hepatocyte Fa2N-4 cells and 
requisite media were purchased from Xenotech (Lenexa, KS). 
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Fa2N-4 Cell Studies 
According to manufacturer recommendations, six-well plates were seeded with 1.3 × 10
6 
cells/well, and kept in an incubator set at 37°C, 5% carbon dioxide and 95% relative 
humidity. Plates were exposed to plain media (control), rifampin (positive control) or garlic 
at indicated concentrations. For multi-day experiments, fresh rifampin- and garlic-
containing media were replaced daily. All spike solutions (i.e., garlic, rifampin, diclofenac, 
midazolam) were prepared in dimethylsulfoxide (DMSO) and added to a final DMSO 
concentration of 0.1% v/v. Each treatment was replicated four times. 
At the indicated time point, media (i.e., garlic, rifampin, or plain media) was removed from 
cells, the cells were washed with fresh media, and fresh media containing respective 
concentrations of either rifampin or garlic, and the CYP probe substrates (i.e., diclofenac 
100 µM for CYP2C9 and midazolam for CYP3A4) were placed. After six hours of 
incubation with diclofenac (100 µM), the culture media was removed and an aliquot was 
analyzed for 4'-hydroxydiclofenac
 using a modified LC-MS assay procedure based on that 
described by Mills et al [11]. The formation rate of 4'-hydroxydiclofenac
 in each well was 
typically 3-500 pmole/hr. The results for CYP2C9 activity is normalized based on 
hydroxylation rate of 4’-hydroxy-diclofenac/hr/mg of cell protein, and expressed as the ratio 
or fold over that observed for control, untreated cells. To assess CYP3A4 activity at the 
designated day after garlic exposure, the cells were incubated with fresh media containing 
rifampin or garlic and midazolam (100 μM). After 15 minute incubation, the media was 
removed and an aliquot was analyzed for α-hydroxymidazolam using a LC-MS analytical 
method modified from previously published methods [19,  20]. The formation rate of α-
hydroxymidazolam in each well was 8–10 pmole/15 min. The results for CYP3A4 activity is 
normalized based on hydroxylation rate of α-hydroxymidazolam/min/mg of cell protein, and 
expressed as the ratio or fold over that observed for control, untreated cells. In a separate 
experiment, the 15 minute incubation time is verified to be within linear range of product 
formation rate. 
RNA Analysis 
For RNA analysis, Fa2N-4 cells were grown on six-well tissue culture plates coated with 
4% (w/v) collagen. Total RNA was extracted from cells on day 5 of exposure to plain 
medium, rifampin or garlic extract using the mini RNeasy kit
  according to instructions 
provided by the manufacturer (QIAGEN,
 Valencia, CA). RNA (100 ng) was subjected to 
validated real-time polymerase chain reaction (RT-PCR) (ABI, Foster City, CA) assay 
using ABI Prism 7700 Sequence Detection System [21] to determine the CYP3A4 and 
CYP2C9 mRNA transcripts, and normalized using human beta-glucuronidase (hGUS) 
house-keeping control gene transcript. The data were expressed as fold induction 
compared to RNA collected from control cells treated with plain media. Statistical
 analysis 
for increased levels of RNA in samples compared with
 vehicle-treatment was conducted 
using the two-sample, unpaired
  Student's  t test, with p < 0.05  indicating  significant 
differences. Analysis of variance was used for comparisons between
 multiple treatments 
(more than two samples); post-hoc paired comparisons were conducted for the purpose of 
rank ordering multiple inducers. 
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